222 Jacobs Street is a newly constructed 430,000 square-foot, 9-story life science and technology building located in the new Cambridge Crossing neighborhood in Cambridge, MA. Completed in 2019, the state-of-the-art building includes a sun-soaked lobby with a two-story green wall, a shared conference center, 120-space bike room with showers, and below-grade parking. The building is 100% leased and is the home of the Philips North American Innovation Center and is also occupied by Cerevel Therapeutics. With Wired Score, LEED, and WELL certifications, 222 Jacobs is built to the highest of standards and is designed for today’s leading innovation companies. Tenants include Philips and Cereval Therapeutics.